MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 297.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,022 | -59.0% | 24,427 | +6.3% | 0.00% | -100.0% |
| Q2 2023 | $75,594 | -20.5% | 22,977 | -0.7% | 0.00% | 0.0% |
| Q1 2023 | $95,056 | -26.0% | 23,128 | +5.4% | 0.00% | 0.0% |
| Q4 2022 | $128,539 | -10.1% | 21,935 | +4.0% | 0.00% | 0.0% |
| Q3 2022 | $143,000 | +50.5% | 21,086 | +3.0% | 0.00% | 0.0% |
| Q2 2022 | $95,000 | +53.2% | 20,481 | +31.7% | 0.00% | – |
| Q1 2022 | $62,000 | -35.4% | 15,551 | +0.6% | 0.00% | -100.0% |
| Q4 2021 | $96,000 | -32.9% | 15,451 | +1.9% | 0.00% | 0.0% |
| Q3 2021 | $143,000 | -29.2% | 15,158 | +1.8% | 0.00% | -50.0% |
| Q2 2021 | $202,000 | -21.7% | 14,896 | -6.6% | 0.00% | 0.0% |
| Q1 2021 | $258,000 | -38.9% | 15,952 | +0.5% | 0.00% | -50.0% |
| Q4 2020 | $422,000 | +47.0% | 15,873 | +2.9% | 0.00% | +33.3% |
| Q3 2020 | $287,000 | +23.2% | 15,423 | +54.6% | 0.00% | 0.0% |
| Q2 2020 | $233,000 | – | 9,978 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $4,564,000 | 3.47% |
| NEA Management Company, LLC | 11,963,649 | $68,552,000 | 3.24% |
| Sarissa Capital Management LP | 3,750,000 | $21,487,000 | 1.78% |
| VHCP Management III, LLC | 1,561,389 | $8,947,000 | 1.78% |
| VHCP Management II, LLC | 922,514 | $5,286,000 | 1.39% |
| Ghost Tree Capital, LLC | 800,000 | $4,584,000 | 0.87% |
| BVF INC/IL | 1,180,553 | $6,765,000 | 0.51% |
| Sio Capital Management, LLC | 166,250 | $953,000 | 0.23% |
| Rock Springs Capital Management LP | 1,233,000 | $7,065,000 | 0.22% |
| DAFNA Capital Management LLC | 108,463 | $621,000 | 0.21% |